Erratum


A statement made in the Efficacy section was written incorrectly. It should have appeared as follows:

The percentage of patients who progressed at 5 years (primary endpoint) was 42% versus 42.7%, respectively (odds ratio, 1.03; 95% CI, 0.55-1.92; P = .9272).

The authors regret this error.

Ancillary